Sign In
Buy DXCM
$86.94
-0.370 (-0.424%)
At Close: Aug 04, 2026
DexCom (DXCM) Misses Q4 Earnings Estimates
06:15pm, Thursday, 13'th Feb 2025
DexCom (DXCM) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.50 per share a year ago.
Dexcom beats fourth-quarter sales, reiterates 2025 revenue forecast
05:09pm, Thursday, 13'th Feb 2025
Medical device maker Dexcom beat fourth-quarter sales estimates helped by resilient demand for its continuous glucose monitors (CGMs) used by patients with diabetes.
Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations
04:12pm, Thursday, 13'th Feb 2025
Dexcom stock fell late Thursday after the company missed fourth-quarter profit expectations by a nickel per share. The post Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations appeared first on
DXCM Q4 Earnings to Reflect Market Expansion & Stelo Impact?
07:21am, Tuesday, 11'th Feb 2025
DexCom Q4 results are likely to reflect strong growth on the back of U.S. sales expansion, global gains and Stelo traction, driving momentum and market expansion into 2025.
Countdown to DexCom (DXCM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
10:21am, Monday, 10'th Feb 2025
Evaluate the expected performance of DexCom (DXCM) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
Should You Buy DexCom Stock Before Feb. 13?
09:30am, Thursday, 06'th Feb 2025
DexCom (DXCM 1.51%) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track glucose levels.
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
09:15am, Monday, 03'rd Feb 2025
Medical device specialist DexCom (DXCM -0.90%) has substantially underperformed the market over the trailing-12-month period. The diabetes-focused company disappointed investors last year due to unimp
Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years
08:45am, Monday, 03'rd Feb 2025
The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the performance of many top stocks reflects this reality. However, a share price moving
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and fiscal year 2024 financial results after market close on Thursday, February 13, 2
DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?
11:50am, Tuesday, 21'st Jan 2025
DexCom Inc. DXCM is off to a strong start in 2025, with its stock rallying 5.7% following the release of its preliminary results for the fourth quarter and fiscal 2024 on Jan. 13, 2025. The company'
DexCom: Fairly Priced In 2025; Why I'm Not Expecting A Share Price Comeback
04:43pm, Friday, 17'th Jan 2025
DexCom, Inc.'s growth is impressive but limited by its niche market, with my projected ceiling being ~$7.5bn in peak annual revenues. Despite positive Q4 2024 results, DexCom's stock is fairly valued,
2 Healthcare Stocks to Buy Hand Over Fist in January
05:22am, Thursday, 16'th Jan 2025
Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a single 30-day period.
DexCom Stock Up Following Strong Preliminary Q4 Results & 2025 Outlook
09:16am, Tuesday, 14'th Jan 2025
DXCM's top line reflects strong demand for its CGM sensors. International expansion is also driving sales higher.
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
09:26am, Monday, 13'th Jan 2025
DXCM continues to raise optimism among investors owing to its strong product portfolio.
Dexcom forecasts 2025 revenue mostly in-line with expectations
07:43am, Monday, 13'th Jan 2025
Dexcom forecast total annual revenue in line with Wall Street expectations on Monday, on bets of strong demand for its continuous glucose monitors for diabetes patients.
